The predominant fusion partner for FGFR3 in GBM patients is the transforming acidic coiled-coil 3 (TACC3), resulting in an in-frame fusion of the FGFR3 N-terminus with the TACC3 C-terminus. This evidence concerns the gene TACC3 and glioblastoma.